Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.

Faster global financial news!

Gene-editing stocks rose on U.S. markets, with Beam Therapeutics up nearly 10%, CRISPR Therapeutics up over 7%, and Futa Pharmaceutical up over 4%.

06/01/2026 06:55 UTC
Share
Complaint Report
Gene-editing stocks rose on U.S. markets, with Beam Therapeutics up nearly 10%, CRISPR Therapeutics up over 7%, and Futa Pharmaceutical up over 4%.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
i
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.